Friday
03.05.2021
11:22 AM
Login form
Search
Calendar
Entries archive

Africa Live News

Main » 2020 » December » 20 » kENUP Foundation: EIB Launches EUR 50 Million Africa Pharmaceutical Manufacturing Initiative
9:13 AM
kENUP Foundation: EIB Launches EUR 50 Million Africa Pharmaceutical Manufacturing Initiative

LUXEMBOURG-Friday 18 December 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- The European Investment Bank today launched the first ever scheme to strengthen local production of Active Pharmaceutical Ingredients in Africa and scale up drug manufacturing essential to improve public health. The EIB’s new EUR 50 million pharmaceutical investment initiative, initiated together with kENUP Foundation, will contribute to reducing dependency on drug imports and address medical supply chain weaknesses linked to COVID-19.

The programme will improve availability of specialist drugs and tackle supply chain challenges that currently damage public health across Africa. This new initiative is aligned with World Health Organisation goals and the recently announced cooperation between the EIB and WHO to combat COVID-19 and strengthen health system resilience to better face future pandemics.

Scaling up pharmaceutical investment in Africa will help to protect millions of people from disease and disability and strengthen resilience to ongoing and future pandemics.

“Accelerating high-impact pharmaceutical investment across Africa is crucial to improve public health, address medical supply chain weaknesses and unlock long-term economic development. The European Investment Bank is pleased to launch the first ever-financing initiative to scale up local production of Active Pharmaceutical Ingredients in Africa. This scheme has been designed with African and global experts and builds on the EIB’s unique global technical experience and financing expertise supporting health and innovation investment.” said Thomas Östros, European Investment Bank Vice President.

“COVID-19 has highlighted how public health in Africa is vulnerable to global supply chains and dependent on international production. Increasing local specialist manufacturing of Active Pharmaceutical Ingredients will help to improve the public health of millions of Africans. This new initiative demonstrates how specialist pharmaceutical and financing expertise can create jobs and a better future for Africa.” said Dr Mariângela Batista Galvão Simão, World Health Organisation Assistant Director- General responsible for Access to Medicines and Health Products.

The Active Pharmaceutical Ingredients financing initiative was formally launched earlier today with participation of representatives from the European Investment Bank, World Health Organisation, EDCTP, Global Access in Action at Harvard Law School and kENUP Foundation. Kenyan-based non-profit APIFA (API for Africa) contributed their expertise throughout the process of establishing this financing facility and will act as a non-exclusive promotor to the facility.

“This is a timely facility that will transform the pharmaceutical manufacturing industry on the continent and thus enhance access to essential medicines for vulnerable populations. We call on all relevant stakeholders to now work together to support manufacturers in this transformation journey and ensure the long-term viability of this initiative”, says Gerald Macharia, a founding director of APIFA.

More information can be found at https://www.kenup.eu.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005724/en/

Contacts

Press:
Tobias Mac-Lean
maclean@kenup.eu

Permalink : https://www.aetoswire.com/news/kenup-foundation-eib-launches-eur-50-million-africa-pharmaceutical-manufacturing-initiative/en

Views: 9 | Added by: africanewsline | Rating: 0.0/0
Total comments: 0
Name *:
Email *:
Code *: